Zheng, W., Wang, J., Zhang, K., Liu, C., Zhang, L., Liang, X., Zhang, L., et al. (2022) Maternal and Infant Outcomes in Women with and without Gestational Diabetes Mellitus in the COVID-19 Era in China: Lessons Learned. Frontiers in Endocrinology, 13, Article ID: 982493.
https://doi.org/10.3389/fendo.2022.982493
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=36482992&query_hl=1

has been cited by the following article:

• TITLE: The Treatment of Gestational Diabetes Mellitus

  AUTHORS: Min Jin, Hongbing Xu

  KEYWORDS: Gestational Diabetes Mellitus, Pregnancy, Diagnosis, Treatment, Impact

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.4, April 28, 2023

  ABSTRACT: Pre-pregnancy glucose metabolism is normal, only during pregnancy diabetes known as gestational diabetes mellitus. Currently, the diagnostic criteria for gestational diabetes mellitus are IADPSG criteria (International Association of Diabetes and Pregnancy Study Group), and 75 g oral glucose tolerance test is recommended at 24 - 28 weeks of gestation. Gestational diabetes is associated with many pregnancy complications, such as macrosomia, preterm delivery and increased cesarean section rates, and neonatal complications such as hypoglycemia, hypoxia, and respiratory distress syndrome. Early identification of high-risk groups can be carried out for early prevention and intervention which are conducive to improving mothers and infants perinatal outcome. For the treatment of gestational diabetes, lifestyle interventions, such as improved diet combined with exercise to control blood sugar, are recommended first. For patients with poor blood glucose control, insulin is recommended for blood glucose control, and oral drug use is still controversial.